pharmaphorum July 22, 2024
Off-the-shelf consumer wearables have shown a benefit when used to monitor the response to treatment in patients with atrial fibrillation (AF) and heart failure (HF).
Researchers in the UK used a Samsung A6 smartphone and Fitbit Charge 2 to collect data from patients being treated for the two conditions over 20 weeks, to see if they could continuously monitor the response to medications and provide clinical information similar to in-person hospital assessment.
The verdict? The wearables were equivalent to standard tests often used in hospitals and clinical trials that require staff time and resources, according to the study, which has been published in the journal Nature Medicine.
Using the devices, the team from the cardAIc group at the University of...
Today's Sponsors
Today's Sponsor